A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
NCT07783425
This study is recruiting at 6 US sites in 5 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to find out how well tilrekimig works, how safe it is, and how it affects the body in adults and adolescents with moderate to severe atopic dermatitis (eczema). Eczema is a condition which can cause dryness, itching, and redness of your skin. The study is seeking participants who: Are aged 12 years or older. Were confirmed to have atopic dermatitis (AD) at least 12 months ago. Are not having an effective treatment result from medicines that are applied on skin for AD. Are considered by their doctors to have moderate to severe AD.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Atopic Dermatitis
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 3
- Ages
- 12 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Pfizer
- Last updated on ClinicalTrials.gov
- October 6, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 2
- Marvel Clinical Research · Huntington Beach, CA
- Northridge Clinical Trials, LLC · Northridge, CA
Georgia · 1
- Marietta Dermatology Clinical Research, Inc. · Marietta, GA
Indiana · 1
- Dawes Fretzin Clinical Research Group, LLC · Indianapolis, IN
Oklahoma · 1
- Vital Prospects Clinical Research Institute., PC · Tulsa, OK
Tennessee · 1
- Clinical Neuroscience Solutions, LLC. · Memphis, TN
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.